Inventor · disambiguated record
Joshua P. Frederick
Also filed as: FREDERICK JOSHUA · FREDERICK JOSHUA P
27 granted patents·15 pending applications·164 citations·filing 2012–2023
96Inventor score
Top patents by PatentIndex Score
42 records- 0198US11344504B1Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2021·Granted May 31, 2022·4 cites·29 claims
- 0298US10285950B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted May 14, 2019·13 cites·20 claims
- 0398US10172808B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jan 8, 2019·19 cites·18 claims
- 0498US10023626B2Polynucleotides encoding immune modulating polypeptidesMODERNATX INC·Filed 2014·Granted Jul 17, 2018·46 cites·17 claims
- 0597US11403008B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2021·Granted Aug 2, 2022·3 cites·29 claims
- 0697US11071716B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2020·Granted Jul 27, 2021·3 cites·20 claims
- 0797US10646549B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2018·Granted May 12, 2020·13 cites·20 claims
- 0896US11000573B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2020·Granted May 11, 2021·3 cites·20 claims
- 0996US10406113B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Sep 10, 2019·7 cites·30 claims
- 1096US10383951B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2018·Granted Aug 20, 2019·7 cites·22 claims
- 1196US10143723B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2018·Granted Dec 4, 2018·8 cites·18 claims
- 1295US11596609B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2022·Granted Mar 7, 2023·1 cites·20 claims
- 1395US10322090B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jun 18, 2019·5 cites·30 claims
- 1495US10322091B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Jun 18, 2019·5 cites·30 claims
- 1594US11003366B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2019·Granted May 11, 2021·4 cites·21 claims
- 1693US10379767B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2018·Granted Aug 13, 2019·5 cites·20 claims
- 1792US10973917B2MRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2019·Granted Apr 13, 2021·4 cites·27 claims
- 1892US10335486B2MRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2018·Granted Jul 2, 2019·8 cites·23 claims
- 1991US10815291B2Polynucleotides encoding immune modulating polypeptidesMODERNATX INC·Filed 2018·Granted Oct 27, 2020·3 cites·15 claims
- 2090US11311602B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2021·Granted Apr 26, 2022·1 cites·31 claims
- 2189US11185510B2Combinations of mRNAs encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2019·Granted Nov 30, 2021·1 cites·26 claims
- 2284US11687256B2Methods of using OX40 ligand encoding polynucleotidesMODERNATX INC·Filed 2022·Granted Jun 27, 2023·0 cites·37 claims
- 2383US2023041964A1Combinations of mrnas encoding immune modulating polypeptides and uses thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 2482US11571463B2Polynucleotides encoding interleukin-12 (IL12) and uses thereofMODERNATX INC·Filed 2022·Granted Feb 7, 2023·0 cites·23 claims
- 2582US2024024422A1Polynucleotides encoding interleukin-12 (il12) and uses thereofMODERNATX INC·Filed 2023·Application pending·0 cites
- 2681US2023346928A1Mrna combination therapy for the treatment of cancerMODERNATX INC·Filed 2023·Application pending·0 cites
- 2780US2023359371A1Methods of using ox40 ligand encoding polynucleotidesMODERNATX INC·Filed 2023·Application pending·0 cites
- 2876US11708396B2Signal-sensor polynucleotides for the alteration of cellular phenotypesMODERNATX INC·Filed 2021·Granted Jul 25, 2023·0 cites·33 claims
- 2976US11660341B2mRNA combination therapy for the treatment of cancerMODERNATX INC·Filed 2021·Granted May 30, 2023·0 cites·31 claims
- 3075US11421011B2Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereofMODERNATX INC·Filed 2018·Granted Aug 23, 2022·1 cites·46 claims
- 3168US11873327B2Polynucleotides encoding tethered interleukin-12 (IL12) polypeptides and uses thereofMODERNATX INC·Filed 2022·Granted Jan 16, 2024·0 cites·44 claims
- 3266US2021269506A1Polynucleotides encoding immune modulating polypeptidesMODERNATX INC·Filed 2020·Application pending·0 cites
- 3361US2019185529A1Signal-sensor polynucleotides for the alteration of cellular phenotypesMODERNATX INC·Filed 2018·Application pending·0 cites
- 3460US2025281583A1Composition of mrna-encoded il15 fusion proteins and methods of use thereofMODERNATX INC·Filed 2022·Application pending·0 cites
- 3560US2014200261A1Signal-sensor polynucleotides for the alteration of cellular phenotypesHOGE STEPHEN G·Filed 2013·Application pending·0 cites
- 3659US2013165343A1Identification of multigene biomarkersAVEO PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3758US2013165337A1Identification of multigene biomarkersAVEO PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 3856US2025213664A1Mrnas encoding checkpoint cancer vaccines and uses thereofMODERNATX INC·Filed 2023·Application pending·0 cites
- 3949US2023081530A1Methods and compositions for treating cancer using mrna therapeuticsMODERNATX INC·Filed 2019·Application pending·0 cites
- 4040US2019241658A1Therapeutic mRNAs encoding anti CTLA-4 antibodiesMODERNATX INC·Filed 2017·Application pending·0 cites
- 4140US2021206818A1Messenger ribonucleic acids for the production of intracellular binding polypeptides and methods of use thereofMODERNATX INC·Filed 2017·Application pending·0 cites
- 4239US2022001026A1Use of mrna encoding ox40l to treat cancer in human patientsMODERNATX INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joshua P. Frederick files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →